How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Upper-Limb Powered Exoskeleton Robot Market
- By Application: Medical Rehabilitation, Industrial Assistance, Military and Defense, Assistive Technology for Disabilities, Research and Development
- By End User: Hospitals and Rehabilitation Centers, Manufacturing and Assembly Plants, Military and Defense Organizations, Research Institutions, Home Care Settings
- By Actuation Technology: Electric Motor Driven, Pneumatic Actuators, Hydraulic Actuators, Series Elastic Actuators
- By Control System: EMG-Based Control, Joystick Control, Brain-Computer Interface (BCI), Predefined Motion Patterns
- By Wearable Design: Exosuits (Soft Exoskeletons), Rigid Frame Exoskeletons, Hybrid Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Medical Rehabilitation leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Upper-Limb Powered Exoskeleton Robot Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Application 5
End User 5
Actuation Technology 4
Control System 4
Wearable Design 3
Companies profiled
Ekso Bionics Holdings Inc.
ReWalk Robotics Ltd.
Cyberdyne Inc.
SuitX (now part of Ottobock)
Bionik Laboratories Corp.
Myomo Inc.
Hocoma AG
Rex Bionics Ltd.
Medrobotics Corporation
B-Temia
Wearable Robotics Association
Technaid
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Ekso Bionics Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →ReWalk Robotics Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Cyberdyne Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →SuitX (now part of Ottobock)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bionik Laboratories Corp.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Myomo Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hocoma AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Rex Bionics Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Medrobotics Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →B-Temia
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Wearable Robotics Association
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Technaid
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Fourier Intelligence
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →ExoAtlet
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Innophys Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,288M by 2033 · 4.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Medical Rehabilitation37.8
- Industrial Assistance14.2
- Military and Defense10.5
- Assistive Technology for Disabilities21.3
- Research and Development16.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$985.8M → $1,552M · 5.8%
Europe$687.1M → $1,106M · 6.1%
Asia Pacific$627.3M → $895.7M · 4.6%
Latin America$388.4M → $619.2M · 6.0%
Middle East and Africa$298.7M → $443.7M · 5.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.572026
4.582027
4.602028
4.612029
4.622030
4.642031
4.652032
4.652033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Ekso Bionics Holdings Inc.16.9
- ReWalk Robotics Ltd.10.6
- Cyberdyne Inc.13.9
- SuitX (now part of Ottobock)8.3
- Bionik Laboratories Corp.13.2
- Myomo Inc.9.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application32.4%
End User23.7%
Actuation Technology16.0%
Control System11.1%
Wearable Design16.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.6
- Europe24.0
- Asia Pacific19.4
- Latin America13.4
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Ekso Bionics Holdings Inc. | 80 | 83 | 86 | 89 | 88 | 88 | 86 |
| ReWalk Robotics Ltd. | 85 | 91 | 76 | 87 | 79 | 78 | 83 |
| Cyberdyne Inc. | 70 | 88 | 65 | 75 | 85 | 66 | 75 |
| SuitX (now part of Ottobock) | 67 | 80 | 71 | 81 | 82 | 80 | 77 |
| Bionik Laboratories Corp. | 69 | 62 | 73 | 61 | 72 | 69 | 68 |
| Myomo Inc. | 69 | 71 | 53 | 53 | 48 | 50 | 57 |
| Hocoma AG | 58 | 42 | 63 | 54 | 58 | 46 | 54 |
| Rex Bionics Ltd. | 43 | 41 | 42 | 52 | 50 | 46 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Ekso Bionics Holdings Inc.
- ReWalk Robotics Ltd.
- Cyberdyne Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Ekso Bionics Holdings Inc. | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| ReWalk Robotics Ltd. | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Cyberdyne Inc. | − | ◐ | − | ✓ | ◐ | ✓ |
| SuitX (now part of Ottobock) | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Bionik Laboratories Corp. | ◐ | − | − | − | ◐ | ◐ |
| Myomo Inc. | ◐ | ✓ | ◐ | − | ◐ | ◐ |
| Hocoma AG | − | − | − | − | ◐ | − |
| Rex Bionics Ltd. | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Ekso Bionics Holdings Inc.86
2ReWalk Robotics Ltd.83
3SuitX (now part of Ottobock)77
4Cyberdyne Inc.75
5Bionik Laboratories Corp.68
6Myomo Inc.57
7Hocoma AG54
8Rex Bionics Ltd.46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Ekso Bionics Holdings Inc.ReWalk Robotics Ltd.
Challenger3
Strong scale, closing on the leaders.
Cyberdyne Inc.SuitX (now part of Ottobock)Bionik Laboratories Corp.
Contender1
Focused players with pockets of strength.
Myomo Inc.
Niche2
Specialists in a single segment or region.
Hocoma AGRex Bionics Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Upper-Limb Powered Exoskeleton Robot Market — a $402M beachhead inside a $6.46B market.
Beachhead (SOM)$402Mobtainable near-term
Serviceable (SAM)$2.51Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Medical Rehabilitation
Best fit — highest urgency & budget in Application.
Economic buyer75 fit
Industrial Assistance
Strong fit — clear ROI and a fast path to value.
End user68 fit
Military and Defense
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Actuation Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Upper-Limb Powered Exoskeleton Robot Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified24%
Evaluation14%
Closed-won6%
$13.9KCAC
$78KLTV
5.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Upper-Limb Powered Exoskeleton Robot Market is a resilient opportunity — $2.59B by 2033, compounding at 3.2%.
TAM · 2025$2.01Btoday
TAM · 2033$2.59Bforecast
CAGR3.2%2027–2033
Cumulative$20.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.59BTotal addressable market
SAM$965MServiceable available market
SOM$158MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.2% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.59BLarge & growingTAM by 2033 at 3.2% CAGR
$965MServiceable nowreachable with today’s model
$158MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.02BBear2.1% CAGR
$2.59BBase3.2% CAGR
$3.31BBull4.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Upper-Limb Powered Exoskeleton Robot Market — a $5.77B market by 2033. Plan: grow share from 6.5% to 11.1%.
Market size · 2033$5.77Btotal addressable
Market CAGR11.0%2027–2033
Target share11.1%from 6.5% today
Revenue ambition$641Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.5% | 11.1% | On track |
| Revenue | $381M | $641M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.4% | 40.4% | At risk |
| Customer retention | 87.9% | 94.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $68M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Upper-Limb Powered Exoskeleton Robot Market conversation — a $7.68B market you can size, segment and defend in minutes.
Market size · 2033$7.68Btotal opportunity
Growth4.8%CAGR to 2033
Addressable buyers1,119+accounts in scope
Typical ROI5.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.6×return on cost, year one
< 4 mopayback period
$97K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Ekso Bionics Holdings Inc.ReWalk Robotics Ltd.Cyberdyne Inc.SuitX (now part of Ottobock)Bionik Laboratories Corp.Myomo Inc.Hocoma AGRex Bionics Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Upper-Limb Powered Exoskeleton Robot Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Upper-Limb Powered Exoskeleton Robot Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Upper Limb Orthotic Systems Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportUpper Limb Orthosis Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportUpper Limb Exoskeleton Robot Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportUpper Humeral Joint Prosthesis Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportUpper Gastrointestinal Stent Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportUpper Gastrointestinal Capsule Endoscopy Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportUpper Extremity Rehabilitation Robotic Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportUpper Extremity Reconstruction Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportUpper Extremity Prosthesis Gloves Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportUpper Extremity Prostheses Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportUpper Extremity Orthotics Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportUpper Extremity Medical Exoskeleton Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.